Without test report, defect acceptable

The failure to examine the IOL and check it for opaqueness was held to be contributory negligence on part of the surgeon. So it confirmed the order holding him liable

DOCTOR, MEDICAL, HEALTH, HEALTH SECTOR
Jehangir B Gai
3 min read Last Updated : Oct 16 2019 | 11:54 PM IST
Sudhakar Chowkekar had developed a cataract in the left eye. After conducting all the pre-operative investigations, he was admitted to Bombay Hospital for surgery by ophthalmic surgeon R C Patel. The intraocular lens (IOL) that had to be implanted was manufactured by Allergan Surgical (USA) and purchased for Rs 3,200 through dealer Shivnesh Phaco & Eye Micro Surgery.

During the post-operative examination, it was found that the lens was opaque and ineffective, due to which vision diminished from 90 per cent to 30 per cent. Chowkekar was advised to undergo corrective surgery. The surgeon also informed Allergan USA's Indian representative, who agreed to bear the cost of the second surgery for removal of the IOL and implant of a new one.

Chowkekar's vision deteriorated further after the second surgery. He had a legal notice issued to the doctor and the implant manufacturer. Patel replied, explaining that the IOL had become opaque, which necessitated a second surgery, resulting in the cornea getting damaged.

Chowkekar filed a complaint before the Maharashtra State Commission against the operating surgeon, the dealer, and the IOL manufacturer through its Indian representative. The manufacturer did not contest the case, but the dealer and the operating surgeon did so jointly. They stated that the IOL manufacturer had a duty to check the quality and functionality of the lens and certify it for safety. They noted that the box containing the lens had been kept sealed till the last minute to avoid contamination, and was opened just when the lens had to be implanted. They added that after the IOL was removed, it was sent to the manufacturer for testing, but the company hdid not respond despite reminders. Failure in improvement of vision even after the second surgery was attributed to corneal changes occurring during the second surgery. They admitted that Chowkekar had become blind, but denied that it was due to their negligence. 

The State Commission held the doctor, the dealer and the manufacturer jointly and severally liable to reimburse the medical expenses of Rs 1,65,364 along with Rs  5 lakh as lump sum and Rs 20,000 towards costs. It was also ordered that these amounts would carry 9 per cent interest if payment was delayed beyond 45 days.

In the appeal, the manufacturer argued that an IOL could become opaque due to various reasons, and blamed the treating doctor of attempting to cover up his negligence by finding fault with the IOL by terming it to be defective. 

The National Commission observed that the defect in the lens was immediately recorded during the postoperative examination. It pointed out that after its removal, the IOL was sent for testing, but the manufacturer had neglected to check it and submit a report despite repeated requests. It concluded that the manufacturer had rightly been held liable.

The National Commission held that the doctor should have examined the lens before implanting it. The failure to examine the IOL and check it for opaqueness was held to be contributory negligence  on the part of the surgeon. So it confirmed the order holding Patel to be jointly and severally liable.

By its order of September 13, 2019, delivered by M Shreesha for the Bench headed by Justice R K Agrawal, the National Commission upheld the order passed by the State Commission and dismissed the appeals with further costs of Rs 25,000 payable by the manufacturer.

The writer is a consumer activist

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

Topics :consumer rights

Next Story